மெர்க் ப்ரெஸ் வெளியீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மெர்க் ப்ரெஸ் வெளியீடுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மெர்க் ப்ரெஸ் வெளியீடுகள் Today - Breaking & Trending Today

Redirecting to Merck Announces Appointment of Head of China & International for Healthcare


Merck Announces Appointment of Head of China & International for Healthcare
Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will serve as a member of the Healthcare Executive Committee, and be based in Shanghai, China. ....

United Kingdom , United States , Chong Chow , Peter Guenter , Head Of China International On , Roche Pharmaceuticals , Merck Press , Healthcare Executive Committee , Anglia Ruskin University , Business Administration , Berlin School Of Economics , Latin America , Middle East , Cardiovascular Metabolism , Global Business Innovation , Executive Board , Supervisory Board , Bayer Healthcare , Berlin School , Merck Press Releases , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் சோவ் , ரோச் மருந்துகள் , மெர்க் ப்ரெஸ் , சுகாதாரம் நிர்வாகி குழு ,

Data from Merck's Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21


Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
Saturday, May 22, 2021 12:20PM IST (6:50AM GMT)
 
New analyses from pivotal BAVENCIO
® study reinforce unique clinical benefits across different subgroups in the treatment of advanced urothelial carcinoma
New data from VISION study of TEPMETKO
® show association between liquid biopsy-identified biomarker and clinical response in
METex14 skipping NSCLC, supporting liquid biopsy as a means for monitoring treatment response
TEPMETKO
Oral presentations from independent studies reinforce the position of ERBITUX
® in 1L RAS wt mCRC and as backbone of treatment in SCCHN
 
Not intended for UK-, US- or Canada-based media ....

United States , Julissa Viana , Eli Lilly , International Metastatic , American Society Of Clinical Oncology , National Cancer Institute , Merck Press , European Commission , Drug Administration , Merck Kga , Global Head Of Development For The Healthcare , Merck Kgaa , Data Consortium , American Society , Clinical Oncology , Annual Meeting , Danny Bar Zohar , Global Head , Data Highlights , Solid Tumor , Product Characteristics , Merck Press Releases , Media Contact , Merck Oncology , Cancer Care , Clinical Benefits ,